Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.
AdaptHealth Corp. reports developments tied to its healthcare-at-home business, which provides home medical equipment, medical supplies and related services. The company’s updates commonly address its Sleep Health, Respiratory Health, Diabetes Health and Wellness at Home categories, including sleep therapy equipment and supplies for obstructive sleep apnea, respiratory services, diabetes-related supplies and in-home wellness offerings.
Recurring AdaptHealth news also covers quarterly and annual results, financial guidance, patient census trends, digital patient engagement through myApp, referral and payor relationships, capitated partnerships, acquisitions and dispositions, credit facility activity, debt ratings and investor conference participation. The company serves Medicare, Medicaid and commercial insurance beneficiaries through a national operating network.
AdaptHealth Corp. (NASDAQ: AHCO) reported strong financial results for Q4 and FY 2020. Q4 net revenue reached $348.4 million, a 133% increase year-over-year, while FY revenue hit $1.06 billion, up 99%. However, the company experienced a net loss of $31.0 million in Q4 and $64.5 million for the full year, primarily due to non-cash charges. AdaptHealth has closed the acquisition of AeroCare and anticipates $50 million in annual cost synergies. The company raised its 2021 guidance, projecting net revenue of $2.18 to $2.35 billion.
AdaptHealth Corp. (NASDAQ: AHCO), a top provider of home medical equipment in the U.S., announced that its Co-CEOs, Luke McGee and Steve Griggs, along with CFO Jason Clemens, will present at two upcoming investor conferences.
- SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 3:00 p.m. ET.
- J.P. Morgan Global High Yield & Leveraged Finance Conference on March 3, 2021, at 11:30 a.m. ET.
Live webcasts will be available on AdaptHealth’s website. The company serves nearly 3 million patients annually through a network of over 500 locations across 46 states.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its financial results for Q4 and full year 2020 on March 4, 2021, before market opening. A conference call is scheduled for 8:30 am ET that same day to discuss the results and business activities. Interested parties can join by calling either (877) 423-9820 (Domestic) or (201) 493-6749 (International). After the call, a replay will be available on the Company’s website for six months under 'Investor Relations.'
AeroCare Holdings has been acquired by AdaptHealth Corp. in a deal valued at approximately $1.1 billion in cash and 31 million shares of stock. This acquisition allows AeroCare’s shareholders, including management and private investors, to become shareholders of AdaptHealth. AeroCare provides home medical equipment and services to over 1 million patients annually, showcasing 20 years of consecutive revenue growth. The merger is anticipated to enhance operational efficiencies and market leadership in the healthcare sector, addressing the needs of chronically ill patients.
AdaptHealth Corp. (NASDAQ: AHCO) has completed its acquisition of AeroCare Holdings Inc. for approximately $1.1 billion in cash and stock, enhancing its home healthcare services. The deal includes 31 million shares of AdaptHealth common stock, subject to shareholder approval. This acquisition enables AdaptHealth to reach nearly 3 million patients across 46 states through over 500 locations. The company will be co-led by AdaptHealth CEO Luke McGee and AeroCare CEO Steve Griggs while expanding its Board of Directors. The transaction was funded through senior notes and credit facility adjustments.
AdaptHealth Corp. (NASDAQ: AHCO) is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 10:00 am EST. The conference runs from January 11-14, 2021, and will be conducted virtually. Interested parties can access a live webcast and replay via the Investors section on www.adapthealth.com. AdaptHealth is a prominent provider of home medical equipment and services, catering to over 1.8 million patients annually across the U.S. through its network of 269 locations.
AdaptHealth Corp. (NASDAQ: AHCO) has priced its public offering of 8,000,000 shares of Class A Common Stock at $33.00 per share, aiming for gross proceeds of approximately $239.25 million. The offering includes 7,250,000 shares from the Company and 750,000 from a selling stockholder, with a 30-day option for underwriters to purchase an additional 1,200,000 shares. Proceeds will fund the acquisition of AeroCare Holdings, Inc. and general corporate purposes. The offering is set to close on January 8, 2021, pending customary conditions.
AdaptHealth Corp. (NASDAQ: AHCO) has initiated a public offering of 7,000,000 shares of its Class A Common Stock, with an additional 1,000,000 shares offered by certain selling stockholders. The offering may also include a 30-day option for underwriters to purchase up to 1,200,000 additional shares. Proceeds will primarily finance the acquisition of AeroCare Holdings, with the remainder allocated for general corporate purposes. The company will not gain any proceeds from shares sold by selling stockholders, and the offering's completion is independent of the AeroCare acquisition.
AdaptHealth Corp. (NASDAQ: AHCO) has priced a $500 million offering of 4.625% senior notes due 2029. Proceeds will fund the acquisition of AeroCare Holdings, with completion expected in Q1 2021, pending customary conditions. If the acquisition isn’t finalized by May 31, 2021, the notes will be redeemed at 100% of their principal. The offering is exclusively for qualified institutional buyers and has not been registered under the Securities Act. AdaptHealth serves approximately 1.8 million patients across 41 states, providing essential home healthcare equipment and services.
AdaptHealth Corp. (NASDAQ: AHCO) has initiated an offering of $500 million senior notes due 2029 through its subsidiary, AdaptHealth LLC. The proceeds will be held in escrow until the completion of the acquisition of AeroCare Holdings, Inc. The acquisition is projected to close in Q1 2021, with potential redemption of the notes if not completed by May 31, 2021. The notes will be guaranteed by various subsidiaries, and are offered exclusively to qualified institutional buyers. This press release does not constitute an offer to sell securities.